Literature DB >> 19348973

Why we will remain pragmatists: four problems with the impractical mechanistic framework and a better solution.

Andrew D Oxman1, Carl Lombard, Shaun Treweek, Joel J Gagnier, Malcolm Maclure, Merrick Zwarenstein.   

Abstract

Mesh：

Year:  2009        PMID： 19348973     DOI： 10.1016/j.jclinepi.2008.08.015

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  12 in total

1.  Explaining pragmatic trials to pragmatic policy-makers.

Authors:  Malcolm Maclure
Journal:  CMAJ       Date:  2009-04-16       Impact factor: 8.262

2.  What kind of randomized trials do we need?

Authors:  Merrick Zwarenstein; Shaun Treweek
Journal:  CMAJ       Date:  2009-04-16       Impact factor: 8.262

3.  Integrating Measurement-Based Care into Treatment for Autism Spectrum Disorder: Insights from a Community Clinic.

Authors:  Tyler C McFayden; Alyssa J Gatto; Angela V Dahiya; Ligia Antezana; Yasuo Miyazaki; Lee D Cooper
Journal:  J Autism Dev Disord       Date:  2021-01-02

4.  The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team.

Authors:  Daniel L Riddle; Robert E Johnson; Mark P Jensen; Francis J Keefe; Kurt Kroenke; Matthew J Bair; Dennis C Ang
Journal:  J Clin Epidemiol       Date:  2010-06-17       Impact factor: 6.437

5.  CHARTing a Path to Pragmatic Tobacco Treatment Research.

Authors:  Erica Cruvinel; Kimber P Richter; Catherine Stoney; Sonia Duffy; Jeffrey Fellows; Kathleen F Harrington; Nancy A Rigotti; Scott Sherman; Hilary A Tindle; Theresa I Shireman; Donna Shelley; Lisa Waiwaiole; Sharon Cummins
Journal:  Am J Prev Med       Date:  2016-10       Impact factor: 5.043

6.  Interprofessional collaborative practice within cancer teams: Translating evidence into action. A mixed methods study protocol.

Authors:  Dominique Tremblay; Danielle Drouin; Ariella Lang; Danièle Roberge; Judith Ritchie; Anne Plante
Journal:  Implement Sci       Date:  2010-07-13       Impact factor: 7.327

7.  Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions.

Authors:  Mary Wells; Brian Williams; Shaun Treweek; Joanne Coyle; Julie Taylor
Journal:  Trials       Date:  2012-06-28       Impact factor: 2.279

Review 8.  Differences between the real and the desired worlds in the results of clinical trials.

Authors:  Regina El Dib; Eliane Chaves Jorge; Amélia Kamegasawa; Solange Ramires Daher; Regina Stella Spagnuolo; Marise Pereira da Silva; Gabriel Pereira Braga; Enilze Volpato; Norma Sueli Pinheiro Módolo; Marluci Betini; Adriana do Valle; Ione Corrêa; Rodrigo Bazan; Ricardo Augusto M B Almeida; Silke Anna Theresa Weber; Silvana Molina; Hugo Yoo; Paulo Villas Boas; José Eduardo Corrente; Joseph Mathew; Anil Kapoor; Raíssa Carvalho; Roberto Bezerra Vital; Leandro Gobbo Braz; Paulo do Nascimento Junior
Journal:  Clinics (Sao Paulo)       Date:  2015-09       Impact factor: 2.365

9.  Form follows function: pragmatic controlled trials (PCTs) have to answer different questions and require different designs than randomized controlled trials (RCTs).

Authors:  Franz Porzsolt; Martin Eisemann; Michael Habs; Peter Wyer
Journal:  Z Gesundh Wiss       Date:  2012-11-07

Review 10.  Making trials matter: pragmatic and explanatory trials and the problem of applicability.

Authors:  Shaun Treweek; Merrick Zwarenstein
Journal:  Trials       Date:  2009-06-03       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.